- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07940673
Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game (ANTICIPATE)
The primary objective of this study is to evaluate the feasibility of using a narrative video game intervention to improve advance care planning (ACP) among care partners of people living with Alzheimer's Disease and Related Dementia. Feasibility will be assessed by evaluating acceptability as well as the fidelity of intervention delivery.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The trial is designed to establish the feasibility and plausibility of using the intervention to alter psychological outcomes, necessary to justify a future Type 1 hybrid effectiveness-implementation trial.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Deepika Mohan, MD, MPH
- Telefonnummer: 412-647-0835
- E-post: mohand@upmc.edu
Studer Kontakt Backup
- Navn: Caroline J Pidro
- Telefonnummer: 412-383-0821
- E-post: cjl13@pitt.edu
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- University of Pittsburgh
-
Ta kontakt med:
- Deepika Mohan, MD, MPH
- Telefonnummer: 412-647-0835
- E-post: mohand@upmc.edu
-
Ta kontakt med:
- Caroline J Pidro
- Telefonnummer: 412-383-0821
- E-post: cjl13@pitt.edu
-
Hovedetterforsker:
- Deepika Mohan, MD, MPH
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Be 18 years or older
- Identify as the primary support person (care partner) for health-related decisions for a person with dementia
Exclusion Criteria:
- the person with dementia has died
- the care partner does not have an email address
- the care partner is unwilling to be recorded
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Pre and Post Intervention (Narrative Video Game) Assessment
Participants in this arm will complete the Surrogate ACP Readiness Survey prior to intervention exposure. Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andre navn:
|
|
Eksperimentell: Post-Intervention (Narrative Video Game) Assessment Only
Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Acceptability of the intervention (co-primary)
Tidsramme: Immediately following intervention exposure
|
Proportion of participants who score the intervention as ≥4/5 on the Acceptability of Intervention Measure |
Immediately following intervention exposure
|
|
Fidelity of intervention delivery (co-primary)
Tidsramme: 3 months post-intervention exposure
|
Proportion of participants who complete all study tasks |
3 months post-intervention exposure
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Fidelity of intervention receipt
Tidsramme: Pre-intervention to 3 months post-intervention
|
Mean responses to the items on the ACP Engagement Survey for Surrogate Decision makers and then summarized by domain (knowledge, readiness, self-efficacy, contemplation). |
Pre-intervention to 3 months post-intervention
|
|
Fidelity of intervention enactment (self-reported completion of ACP)
Tidsramme: 3 months post-intervention
|
Proportion of participants who report ACP activities after intervention exposure |
3 months post-intervention
|
|
Fidelity of behavior change technique delivery
Tidsramme: Immediately post-intervention
|
Proportion of participants who report the use of behavioral rehearsal during the game or who demonstrate the use of rehearsal during game play. |
Immediately post-intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Amber Barnato, MD, MPH, MS, Dartmouth College
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- STUDY26060072
- R21AG098846 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
All collected and de-identified individual participant data.
IPD-delingstidsramme
It will be made available within 6 months of completion of the study, and will be available for 7 years.
Tilgangskriterier for IPD-deling
We will upload the data to a data repository (ICPSR), and researchers may access it by following the protocols set by the repository.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ANALYTIC_CODE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .